Related Experiment Video
Updated: May 27, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Changing regulation of clinical trials in Europe
1Consultant on Clinical Trials to the Medicines and Healthcare products Regulatory Agency (MHRA), 1 Nine Elms Lane, London, SW8 5NQ, UK. brian.davis@mhra.gsi.gov.uk.
Abstract:
The lack of harmonization of legislation, guidance and procedures for conducting clinical trials in Europe is generally considered unsatisfactory, despite the implementation of the Clinical Trials Directive in 2004. This article outlines the measures being taken by the Clinical Trials Facilitation Group of the Heads of Medicines Agencies and the Ad Hoc Clinical Trials Group of the European Commission to improve authorization, amendment and safety monitoring for clinical trials. It also comments, from a UK perspective, on the current status of the Commission's consultation and impact assessment on potential changes to the Clinical Trials Directive, and anticipates the likely changes in the next 5 years.
More Related Videos
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
06:28E-Patient Counseling Trial (E-PACO): Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Drug Regulation
Preclinical Development: Overview
Drug Control Governance: Regulatory Bodies and Their Impact
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...